COLGATE TOTAL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Colgate Total, and when can generic versions of Colgate Total launch?
Colgate Total is a drug marketed by Colgate Palmolive and is included in one NDA.
The generic ingredient in COLGATE TOTAL is sodium fluoride; triclosan. There are one thousand four hundred and seventy-two drug master file entries for this compound. Additional details are available on the sodium fluoride; triclosan profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for COLGATE TOTAL?
- What are the global sales for COLGATE TOTAL?
- What is Average Wholesale Price for COLGATE TOTAL?
Summary for COLGATE TOTAL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 4 |
| Clinical Trials: | 31 |
| Patent Applications: | 413 |
| DailyMed Link: | COLGATE TOTAL at DailyMed |
Recent Clinical Trials for COLGATE TOTAL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Universidade Federal do Para | Phase 3 |
| University of Baghdad | Phase 3 |
| University of California, San Francisco | Early Phase 1 |
US Patents and Regulatory Information for COLGATE TOTAL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Colgate Palmolive | COLGATE TOTAL | sodium fluoride; triclosan | PASTE;DENTAL | 020231-001 | Jul 11, 1997 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for COLGATE TOTAL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Colgate Palmolive | COLGATE TOTAL | sodium fluoride; triclosan | PASTE;DENTAL | 020231-001 | Jul 11, 1997 | ⤷ Sign Up | ⤷ Sign Up |
| Colgate Palmolive | COLGATE TOTAL | sodium fluoride; triclosan | PASTE;DENTAL | 020231-001 | Jul 11, 1997 | ⤷ Sign Up | ⤷ Sign Up |
| Colgate Palmolive | COLGATE TOTAL | sodium fluoride; triclosan | PASTE;DENTAL | 020231-001 | Jul 11, 1997 | ⤷ Sign Up | ⤷ Sign Up |
| Colgate Palmolive | COLGATE TOTAL | sodium fluoride; triclosan | PASTE;DENTAL | 020231-001 | Jul 11, 1997 | ⤷ Sign Up | ⤷ Sign Up |
| Colgate Palmolive | COLGATE TOTAL | sodium fluoride; triclosan | PASTE;DENTAL | 020231-001 | Jul 11, 1997 | ⤷ Sign Up | ⤷ Sign Up |
| Colgate Palmolive | COLGATE TOTAL | sodium fluoride; triclosan | PASTE;DENTAL | 020231-001 | Jul 11, 1997 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for COLGATE TOTAL
See the table below for patents covering COLGATE TOTAL around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Egypt | 19073 | Antibacterial antiplaque oral composition containing novel styrenephosphonic acid copolymer | ⤷ Sign Up |
| Portugal | 101300 | ⤷ Sign Up | |
| Hungary | T61892 | ⤷ Sign Up | |
| Finland | 880425 | ⤷ Sign Up | |
| Italy | 8948695 | ⤷ Sign Up | |
| Sweden | 512333 | Antibakteriell oral komposition med plack- och tandstensbegränsande verkan | ⤷ Sign Up |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for COLGATE TOTAL
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0579826 | SPC/GB02/042 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: ERTAPENEM ((1R,5S,6S,8R,2'S,4'S)-2-(2-(3-CARBOXYPHENYLCARBAMOYL)PYRROLIDIN-4-YLTHIO)-6-(1-HYDROXYETHYL)-1-METHYLCARBAPENEM-3-CARBOXYLIC ACID), A PHARMACEUTICALLY ACCEPTABLE SALT OR IN VIVO HYDROLYSABLE ESTER THEREOF, ESPECIALLY AS THE MONOSODIUM SALT ERTA; REGISTERED: UK EU/1/02/216/001 20020422 |
| 1912999 | 14C0076 | France | ⤷ Sign Up | PRODUCT NAME: SIMEPREVIR OU L'UN DE SES SELS, INCLUANT LE SEL DE SODIUM DE SIMEPREVIR; REGISTRATION NO/DATE: EU/1/14/924 20140516 |
| 1499331 | SPC/GB13/034 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: IZINOVA CONCENTRATE FOR ORAL SOLUTION. THE ACTIVE SUBSTANCE IS A MIXTURE OF 3 SALTS:SODIUM SULPHATE ANHYDROUS, MAGNESIUM SULPHATE HEPTAHYDRATE AND POTASSIUM SULPHATE.; REGISTERED: BE BE434323 20130220; UK PL34926/0016 20130313 |
| 2563920 | CA 2019 00001 | Denmark | ⤷ Sign Up | PRODUCT NAME: A COMPOUND COMPRISING A MODIFIED OLIGONUCLEOTIDE HAVING A NUCLEOBASE SEQUENCE CONSISTING OF 20 LINKED NUCLEOSIDES ACCORDING TO EP B1 2563920 CLAIM 1 (SEQ ID NO: 80), ...SPECIFICALLY INOTERSEN; AND ITS DERIVATIVES, INCLUDING SODIUM SALTS ...; REG. NO/DATE: EU/1/18/1296 20180710 |
| 0579826 | 02C0041 | France | ⤷ Sign Up | PRODUCT NAME: ERTAPENEM SODIUM; REGISTRATION NO/DATE: EU/1/02/216/001 20020418 |
| 2822954 | 1890030-8 | Sweden | ⤷ Sign Up | PRODUCT NAME: BICTEGRAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR BICTEGRAVIR SODIUM; REG. NO/DATE: EU/1/18/1289 20180625 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
